TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call Transcript - Thomson StreetEvents

TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call Transcript

TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call Transcript - Thomson StreetEvents
TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call Transcript
Published Feb 08, 2021
Published Feb 08, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of TGTX.OQ conference call or presentation 8-Feb-21 1:30pm GMT

  
Report Type:

Transcript

Source:
Company:
TG Therapeutics Inc
Ticker
TGTX.OQ
Time
1:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

TG Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript – 2021-06-22 – US$ 54.00 – Edited Transcript of TGTX.OQ presentation 22-Jun-21 2:00pm GMT

TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-08 – US$ 54.00 – Edited Transcript of TGTX.OQ presentation 8-Jun-21 5:20pm GMT

TG Therapeutics Inc Q1 2021 Earnings Call Transcript – 2021-05-10 – US$ 54.00 – Edited Transcript of TGTX.OQ earnings conference call or presentation 10-May-21 12:30pm GMT

TG Therapeutics Inc ULTIMATE I & II Phase 3 Investor & Analyst Webcast Transcript – 2021-04-16 – US$ 54.00 – Edited Transcript of TGTX.OQ conference call or presentation 16-Apr-21 12:30pm GMT

TG Therapeutics Inc Q4 2020 Earnings Call Transcript – 2021-03-02 – US$ 54.00 – Edited Transcript of TGTX.OQ earnings conference call or presentation 2-Mar-21 1:30pm GMT

TG Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-12 – US$ 54.00 – Edited Transcript of TGTX.OQ presentation 12-Jan-21 7:00pm GMT

TG Therapeutics Inc Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Conference Call Transcript – 2020-12-10 – US$ 54.00 – Edited Transcript of TGTX.OQ conference call or presentation 10-Dec-20 1:30pm GMT

TG Therapeutics Inc at Jefferies Virtual London Healthcare Conference Transcript – 2020-11-17 – US$ 54.00 – Edited Transcript of TGTX.OQ presentation 17-Nov-20 7:20pm GMT

TG Therapeutics Inc ASH Abstract Release Conference Call Transcript – 2020-11-05 – US$ 54.00 – Edited Transcript of TGTX.OQ conference call or presentation 5-Nov-20 1:45pm GMT

TG Therapeutics Inc Annual Shareholders Meeting Transcript – 2020-06-18 – US$ 54.00 – Edited Transcript of TGTX.OQ shareholder or annual meeting 18-Jun-20 1:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call Transcript" Feb 08, 2021. Alacra Store. May 05, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/TG-Therapeutics-Inc-Announces-UKONIQ-umbralisib-FDA-Approval-Conference-Call-T13619743>
  
APA:
Thomson StreetEvents. (2021). TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call Transcript Feb 08, 2021. New York, NY: Alacra Store. Retrieved May 05, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/TG-Therapeutics-Inc-Announces-UKONIQ-umbralisib-FDA-Approval-Conference-Call-T13619743>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.